Peripheral lymph node recurrence of tuberculosis after ustekinumab treatment

Archives of Dermatology

Volumn 148, Issue 11, 2012, Pages 1332-1333

  Sánchez Moya, Ana I ^a   Daudén, Esteban ^b  

^a HOSPITAL VIRGEN DE LA SALUD   (Spain)

^b HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; INFLIXIMAB; ISONIAZID; PYRAZINAMIDE; TOPICAL AGENT; USTEKINUMAB;

ADULT; ARTICLE; ASTHENIA; CASE REPORT; DISEASE CONTROL; DISEASE SEVERITY; DRUG WITHDRAWAL; FEMALE; FEVER; FOLLOW UP; HUMAN; HUMAN TISSUE; LYMPH NODE BIOPSY; LYMPHADENITIS; MYCOBACTERIUM TUBERCULOSIS; PHOTOTHERAPY; PRIORITY JOURNAL; PSORIASIS; PSORIASIS SEVERITY INDEX; RECURRENT INFECTION; TUBERCULOUS LYMPHADENITIS;

ADULT; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTITUBERCULAR AGENTS; DERMATOLOGIC AGENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MYCOBACTERIUM TUBERCULOSIS; PSORIASIS; RECURRENCE; SEVERITY OF ILLNESS INDEX; TUBERCULOSIS, LYMPH NODE;

EID: 84869841655     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2012.2958     Document Type: Article

References (5)

1. Lebwohl M, Leonardi C, Griffiths CE, et al. Long-term safety experience of ustekinumab in patients with moderate-to-severe psoriasis (part I of II): results from analyses of general safety parameters from pooled phase 2 and 3 clinical trials. J Am Acad Dermatol. 2012;66(5):731-741.
2. Khader SA, Partida-Sanchez S, Bell G, et al. Interleukin 12p40 is required for dendritic cell migration and T-cell priming after Mycobacterium tuberculosis infection. J Exp Med. 2006;203(7):1805-1815. (Pubitemid 44036285)
3. Reinhardt RL, Hong S, Kang SJ, Wang ZE, Locksley RM. Visualization of IL-12/23p40 in vivo reveals immunostimulatory dendritic cell migrants that promote Th1 differentiation. J Immunol. 2006;177(3):1618-1627. (Pubitemid 44092497)
4. de Beaucoudrey L, Samarina A, Bustamante J, et al. Revisiting human IL-12Rβ1 deficiency: a survey of 141 patients from 30 countries. Medicine (Baltimore). 2010;89(6):381-402.
5. Lee JS, Song CH, Kim CH, et al. Depressed interleukin-12 production by peripheral blood mononuclear cells after in vitro stimulation with the 30-kDa antigen in recurrent pulmonary tuberculosis patients. Med Microbiol Immunol. 2003;192(2):61-69. (Pubitemid 36714122)